{"schema_version":"secwatch.filing_event.v1","accession":"0001127703-26-000018","form_type":"8-K","ticker":"PRA","cik":"0001127703","company_name":"PROASSURANCE CORP","filed_at":"2026-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:31.986236+00:00","generated_at":"2026-05-14T23:13:34.182803+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"ProAssurance Q1 operating income $12.7M; merger with Doctors Company targets June 30 close","bullets":["Net income $8.5M ($0.16 diluted EPS); operating income $12.7M ($0.25 diluted EPS).","Consolidated net premiums written $258.6M; Specialty P&C renewal premium increases 6% (cumulative >80% since 2018).","Non-GAAP combined ratio improved 2.3 points to 109.9%; expense ratio improved 0.3 points.","Merger with The Doctors Company awaits regulatory approvals in CA and PA; target close by June 30, 2026.","Book value per share $25.94, down $0.30 from year-end; adjusted book value $27.86."],"urls":{"canonical":"https://secwatch.observer/filing/0001127703-26-000018","json":"https://secwatch.observer/filing/0001127703-26-000018.json","markdown":"https://secwatch.observer/filing/0001127703-26-000018.md","text":"https://secwatch.observer/filing/0001127703-26-000018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1127703/000112770326000018/0001127703-26-000018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1127703/000112770326000018/pra-20260505.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T23:13:34.182803+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6ea59ebe13060a923ab42dea112106efe80fe5ef","claim":"PROASSURANCE CORP reported the three months ended March 31, 2026 results: net income net income of $8.5 million, or $0.16 per diluted share, EPS $0.16 per diluted share.","evidence_excerpt":"reported net income of $8.5 million, or $0.16 per diluted share","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1127703/000112770326000018/0001127703-26-000018-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended March 31, 2026"},{"label":"Net income","value":"net income of $8.5 million, or $0.16 per diluted share"},{"label":"EPS","value":"$0.16 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}